Use of Antibiotics and Mortality in Women: Does Duration of Exposure Matter?

The integrity of microorganisms which reside in the human gut (gut microbiota) is important for our health and survival. The human intestine contains about 1014 microbes, 10× the number of cells in the entire body.1 Overall, these microorganisms have a biomass of about 1.5 kg1 and contain >5 million genes (gut microbiome), >100× those in the host.2 Gut microbiome has an intense enzymatic and metabolic production that equals that of the liver.2 These microbes are obligatory anaerobes for >99%, belong to 500 to 1000 diverse species, and their density progressively increases from the stomach (101 bacteria per gram of stomach) to colon (107 bacteria per gram of colon).3 Firmicutes and Bacteroides are the most prevalent species. Some of these microorganisms reside in the lumen, while others adhere to mucus or directly to the gut epithelium. Notably, >60% of these bacteria cannot be identified by stool culture, thereby requiring complex DNA sequencing techniques. Colonization of the host’s gut by microbes starts at birth during transit in the birth canal and through bacteria present in the mother’s milk.1 The composition of the gut microbiota varies not only among host species, but also among different individuals, and is importantly affected by diet.3

[1]  J. Manson,et al.  Duration and Life-Stage of Antibiotic Use and Risks of All-Cause and Cause-Specific Mortality , 2019, Circulation research.

[2]  J. Manson,et al.  Duration and life-stage of antibiotic use and risk of cardiovascular events in women. , 2019, European heart journal.

[3]  L. Rice,et al.  Duration of Antibiotic Therapy: Shorter Is Better , 2019, Annals of Internal Medicine.

[4]  T. Hoffmann,et al.  Adverse events in people taking macrolide antibiotics versus placebo for any indication. , 2015, The Cochrane database of systematic reviews.

[5]  Haipeng Xiao,et al.  The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk. , 2015, Journal of the American College of Cardiology.

[6]  T. Farid,et al.  Azithromycin and Risk of Cardiovascular Death: A Meta-Analytic Review of Observational Studies , 2015, American journal of therapeutics.

[7]  C. Forrest,et al.  Association of antibiotics in infancy with early childhood obesity. , 2014, JAMA pediatrics.

[8]  Harry J. Flint,et al.  The gut microbiota, bacterial metabolites and colorectal cancer , 2014, Nature Reviews Microbiology.

[9]  L. Simonato,et al.  Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy. , 2014, American journal of epidemiology.

[10]  C. Prantera,et al.  Antibiotics and Inflammatory Bowel Diseases , 2013, Digestive Diseases.

[11]  H. Svanström,et al.  Use of azithromycin and death from cardiovascular causes. , 2013, The New England journal of medicine.

[12]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[13]  Jeffrey M Schussler,et al.  Drug-induced QT interval prolongation: mechanisms and clinical management , 2012, Therapeutic advances in drug safety.

[14]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[15]  J. Gordon,et al.  Honor thy symbionts , 2003, Proceedings of the National Academy of Sciences of the United States of America.